UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4919-4928

2017

Volltextzugriff (PDF)

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers

NPJ precision oncology, 2023-02, Vol.7 (1), p.18-18, Article 18

2023

Volltextzugriff (PDF)

Abstract 5656: Quantitative measurement of PDL1 expression across tumor types using laser capture microdissection and reverse phase protein microarray

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5656-5656

2017

Volltextzugriff (PDF)

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e002179

2021

Volltextzugriff (PDF)

Abstract P2-07-05: Activation of the AKT/mTOR signaling pathway is associated with response to the combination of endocrine therapy and CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-07-05

2022

Volltextzugriff (PDF)

Abstract PS5-28: Multiomic advanced diagnostics for CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-28-PS5-28

2021

Volltextzugriff (PDF)

Abstract 3290: The Side-Out Foundation Metastatic Breast Cancer Database, an open-access portal for multi-omic molecular data and more

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3290-3290

2018

Volltextzugriff (PDF)

CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer for treatment selection and response prediction

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13029-e13029

2020

Volltextzugriff (PDF)

Abstract 3129: PD-L1 expression differs across cancer metastatic sites from breast tumors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3129-3129

2018

Volltextzugriff (PDF)

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

Breast cancer research and treatment, 2014-10, Vol.147 (3), p.579-588

2014

Volltextzugriff (PDF)

Predictive value of topoisomerase 1 by immunohistochemistry (TOP1 IHC) in patients with metastatic breast cancer receiving irinotecan-based therapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1037-1037

2016

Volltextzugriff (PDF)

Androgen receptor activation in HER2-negative breast cancer liver metastases

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11527-11527

2016

Volltextzugriff (PDF)

Multi-omic profiling of metastatic lesions to guide treatment selection: The Side Out 2 trial experience

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1077-1077

2018

Volltextzugriff (PDF)

Abstract P1-07-23: Pathway activation mapping of metastatic breast cancer identifies potential organ-specific signatures: Implications for patient stratification to targeted treatment

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-07-23

2015

Volltextzugriff (PDF)

A pilot study utilizing molecular profiling to find potential targets and select individualized treatments for patients with metastatic breast cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS11123-TPS11123

2013

Volltextzugriff (PDF)

Enterprise telecom management

Network World, 2002-04, Vol.19 (13), p.47

Bryant Dunetz

2002

Volltextzugriff (PDF)

International connections

Network World, 2001-12, Vol.18 (51), p.42

Bryant Dunetz

2001

Volltextzugriff (PDF)

Virtual private networks

Network World, 2001-09, Vol.18 (36), p.39

Bryant Dunetz

2001

Volltextzugriff (PDF)

Enterprise telecom management; These tools can help firms with large voice and data budgets track their assets and reduce expenses

Network world, 2002-04, p.47-47

Dunetz, Bryant

2002

Volltextzugriff (PDF)

International connections; Glut in capacity of transoceanic cables is driving prices down

Network world, 2001-12, p.42-42

Dunetz, Bryant

2001

Volltextzugriff (PDF)

VIRTUAL PRIVATE NETWORKS; Our guidelines for choosing what type of connection to use for VPNs will tell you how DSL stacks up against alternatives

Network world, 2001-09, p.39-39

Dunetz, Bryant

2001

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(19)
magazinearticle
(3)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(6)
Network World
(6)
Journal Of Clinical Oncology
(5)
Breast Cancer Research And Treatment
(1)
Clinical Cancer Research
(1)
Journal For Immunotherapy Of Cancer
(1)
Molecular Oncology
(1)
Npj Precision Oncology
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

Abstract 5656: Quantitative measurement of PDL1 expression across tumor types using laser capture microdissection and reverse phase protein microarray

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

Abstract P2-07-05: Activation of the AKT/mTOR signaling pathway is associated with response to the combination of endocrine therapy and CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer

Abstract PS5-28: Multiomic advanced diagnostics for CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer

Abstract 3290: The Side-Out Foundation Metastatic Breast Cancer Database, an open-access portal for multi-omic molecular data and more

CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer for treatment selection and response prediction

Abstract 3129: PD-L1 expression differs across cancer metastatic sites from breast tumors

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

Predictive value of topoisomerase 1 by immunohistochemistry (TOP1 IHC) in patients with metastatic breast cancer receiving irinotecan-based therapy

Androgen receptor activation in HER2-negative breast cancer liver metastases

Multi-omic profiling of metastatic lesions to guide treatment selection: The Side Out 2 trial experience

Abstract P1-07-23: Pathway activation mapping of metastatic breast cancer identifies potential organ-specific signatures: Implications for patient stratification to targeted treatment

A pilot study utilizing molecular profiling to find potential targets and select individualized treatments for patients with metastatic breast cancer

Enterprise telecom management

International connections

Virtual private networks

Enterprise telecom management; These tools can help firms with large voice and data budgets track their assets and reduce expenses

International connections; Glut in capacity of transoceanic cables is driving prices down

VIRTUAL PRIVATE NETWORKS; Our guidelines for choosing what type of connection to use for VPNs will tell you how DSL stacks up against alternatives

Suchergebnisse filtern